Lv5
1368 积分 2023-09-11 加入
EGFR- and HER3-targeted bispecific antibody-drug conjugate demonstrates anti-tumor activity in metastatic castration-resistant prostate cancer
2天前
已完结
The histone-modified landscape: Core mechanisms of osimertinib resistance in EGFR-mutant lung cancer
5天前
已完结
ErbB/HER family in cancer immunology: therapeutic advances and mechanisms
5天前
已关闭
Secretory autophagy mediates SLC16A3/MCT4-dependent lactate secretion to drive metastatic progression in triple-negative breast cancer
9天前
已完结
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition
1个月前
已完结
Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome
1个月前
已完结
Inhibiting Endothelial Cell‐Mediated T Lymphocyte Apoptosis with Integrin‐Targeting Peptide‐Drug Conjugate Filaments for Chemoimmunotherapy of Triple‐Negative Breast Cancer
1个月前
已完结
Discovery of a molecular glue for EGFR degradation
1个月前
已完结
Effective Degradation of Wild‐Type and Mutant EGFR Using Self‐Assembling Peptide‐Derived PROTAC Nanoparticles (NanoTACs) for Cancer Therapy
4个月前
已完结
Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway
4个月前
已完结
皖公网安备34019202002308
